Activities Report of the Generic Drugs Program | GDUFA II Quarterly Performance

[FDA]

In section VI(C)(2) of the Generic Drug User Fee Amendments Reauthorization for Fiscal Years 2018-2022 (GDUFA II Commitment Letter), FDA committed to publishing quarterly metrics.


Baca selengkapnya di : http://www.fda.gov...